Navigation Links
Rice wins $1.2 million for heart-valve tissue research

A team of bioengineers from Rice University is bringing a promising new strategy for growing replacement heart valves closer to reality, thanks to a four-year, $1.2 million grant from the National Institutes of Health. The team hopes to use gel-like materials to generate three-dimensional patterns called scaffolds that can simultaneously mimic the complex structural and physical properties of heart-valve tissues and guide the behavior of tissue-forming cells.

Tissue-engineering researcher Jane Grande-Allen, the lead investigator on the grant, said researchers once believed that replacement heart valves would be one of the easiest and first tissues that could be grown in the laboratory. At just a millimeter thick, the rugged flaps of tissue in heart valves seemed simple enough when researchers first started trying to engineer them in the mid-1990s.

"It's ironic because they turned out to be one of the most difficult and complex tissues of all," said Grande-Allen, associate professor in bioengineering at Rice.

Grande-Allen said it's been difficult for engineers to find synthetic materials that truly mimic the complex structure and mechanical properties of heart-valve "leaflets," the tough yet flexible flaps of tissue that form a tight seal to prevent blood from flowing backward each time the heart pumps. Having materials that can both mimic the leaflets' microscopic structure and act as a pattern for tissue-forming stem cells has been a missing link in growing replacement heart valves.

Each aortic or pulmonary heart valve contains a trio of leaflets. Prior to each heartbeat, the leaflets open, like the petals of a blooming flower, allowing blood to flow into one of the heart's chambers. Then the leaflets fold back, interlocking with one another to form a tight seal that prevents blood from flowing backward. In cases of heart-valve disease, the valves don't seal properly, and the heart must pump much harder to deliver sufficient amounts of blood.

More than 90,000 Americans are hospitalized each year for heart-valve disease, and with too few human valves available for transplant, the most common surgical options are mechanical valves, which are noisy and require patients to stay on anticlotting medications for life, and artificial valves made of biological material, usually from pigs, which wear out after about 15 years.

Ideally, tissue engineers would like to grow living valves that use a patient's own cells to eliminate the risk of tissue rejection. But engineers have struggled to find nontoxic, biodegradable materials that can act as a scaffold to guide the cells' behavior. The ideal scaffold will have the same mechanical properties of a valve so that it can be surgically implanted and function as a valve, even as cells grow new tissue to replace it.

Grande-Allen said the fact that valve leaflets have three distinct layers has presented serious complications to creating scaffolds. Leaflets have a soft, malleable layer sandwiched between denser outer layers. The soft layer adds flexibility and sits between outer layers that have subtly different properties. The upshot is that to truly mimic the valves, engineers must design a multilayered scaffold.

"That hasn't been done before, but we have a real shot at success with some of the new methods that have been developed here at Rice in recent months that will allow us to cross-link, layer and reinforce hydrogel scaffolds to have spatially varying mechanical behavior," Grande-Allen said.

Grande-Allen and co-principal investigator Jennifer West, department chair and the Isabel C. Cameron Professor of Bioengineering at Rice, will work with several graduate students to create a multilayered, patterned scaffold with new techniques initially developed by West's team and then further refined in collaboration with Grande-Allen's laboratory. The key technique is one that allows researchers to selectively reinforce soft, nontoxic polymer scaffolds so that they'll mimic the various leaflet layers and won't peel apart.

"We're taking a very pragmatic approach," Grande-Allen said. "We have the tools to make a lot of headway in designing appropriate patterns, but we want to make certain the class of materials that we're planning to work with will ultimately be translatable to create functional valves."

Grande-Allen's and West's laboratories are located in Rice's BioScience Research Collaborative (BRC), an innovative space where scientists and educators from Rice and other Texas Medical Center institutions work together to conduct research that benefits human medicine and health.


Contact: David Ruth
Rice University

Related medicine news :

1. Amway One by One Campaign for Children Reaches 7 Million Kids
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. International Diabetes Federation awards $2 million to 9 global diabetes research projects
4. New Report: $1 Cigarette Tax Increase Would Raise $418.8 Million for Texas and Cut Youth Smoking
5. New Report: $1 Cigarette Tax Increase Would Raise $18.6 Million for Montana and Cut Youth Smoking
6. New Report: $1 Cigarette Tax Increase Would Raise $24.8 Million for Wyoming and Cut Youth Smoking
7. New Report: $1 Cigarette Tax Increase Would Raise $43.3 Million for Utah and Cut Youth Smoking
8. New Report: $1 Cigarette Tax Increase Would Raise $113.9 Million for Colorado and Cut Youth Smoking
9. New Report: $1 Cigarette Tax Increase Would Raise $65.3 Million for Iowa and Cut Youth Smoking
10. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
11. America's Hidden Pandemic: 100 Million Suffer From Sleep Problems
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: